[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE380546T1 - Antazide und laxative magnesiumoxid-tablette - Google Patents

Antazide und laxative magnesiumoxid-tablette

Info

Publication number
ATE380546T1
ATE380546T1 AT02745874T AT02745874T ATE380546T1 AT E380546 T1 ATE380546 T1 AT E380546T1 AT 02745874 T AT02745874 T AT 02745874T AT 02745874 T AT02745874 T AT 02745874T AT E380546 T1 ATE380546 T1 AT E380546T1
Authority
AT
Austria
Prior art keywords
tablet
magnesium oxide
antacid
oxide particles
laxative
Prior art date
Application number
AT02745874T
Other languages
English (en)
Inventor
Mitsuhiro Sofue
Isamu Kawamura
Shigeo Yamao
Hideaki Baba
Shiro Horie
Yoko Abe
Hisae Sofue
Original Assignee
Kyowa Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Chem Ind Co Ltd filed Critical Kyowa Chem Ind Co Ltd
Application granted granted Critical
Publication of ATE380546T1 publication Critical patent/ATE380546T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02745874T 2001-08-27 2002-07-08 Antazide und laxative magnesiumoxid-tablette ATE380546T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001256421 2001-08-27

Publications (1)

Publication Number Publication Date
ATE380546T1 true ATE380546T1 (de) 2007-12-15

Family

ID=19084237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745874T ATE380546T1 (de) 2001-08-27 2002-07-08 Antazide und laxative magnesiumoxid-tablette

Country Status (18)

Country Link
US (1) US7147868B2 (de)
EP (1) EP1421944B1 (de)
KR (3) KR20090065552A (de)
CN (1) CN1262278C (de)
AT (1) ATE380546T1 (de)
AU (1) AU2002318630B2 (de)
CA (1) CA2424554C (de)
DE (1) DE60224056T2 (de)
DK (1) DK1421944T3 (de)
ES (1) ES2296960T3 (de)
HK (1) HK1061641A1 (de)
MX (1) MXPA03003292A (de)
MY (1) MY134676A (de)
NO (1) NO333440B1 (de)
PT (1) PT1421944E (de)
RU (1) RU2284189C2 (de)
TW (1) TWI331044B (de)
WO (1) WO2003018034A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US20050220865A1 (en) * 2004-04-02 2005-10-06 Koleng John J Compressed composition comprising magnesium salt
US20060165759A1 (en) * 2005-01-27 2006-07-27 Warner-Lambert Company Llc Antacid lozenge containing micronized particles
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
EP2204178A4 (de) * 2007-10-29 2010-11-24 Kyowa Chem Ind Co Ltd Abführmittel
WO2010098417A1 (ja) * 2009-02-25 2010-09-02 協和化学工業株式会社 酸化マグネシウム細粒
SG10201401678TA (en) 2009-04-22 2014-06-27 Kyowa Chem Ind Co Ltd Tablet and pestle therefor
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
AU2010293637B2 (en) * 2009-09-08 2015-12-03 Kyowa Chemical Industry Co., Ltd. Antacid and laxative tablet
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
CN102283861A (zh) * 2010-06-17 2011-12-21 杭州赛利药物研究所有限公司 氢氧化镁在制药中的用途以及氢氧化镁制剂和制备方法
PL395069A1 (pl) * 2011-05-31 2012-12-03 Warszawski Uniwersytet Medyczny Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
JP2014224080A (ja) * 2013-05-17 2014-12-04 協和化学工業株式会社 大腸の検査または手術のための処置剤
CN106029103B (zh) 2014-02-25 2021-12-31 神岛化学工业株式会社 医药用或食品添加用的氧化镁颗粒
CN108686222B (zh) * 2018-06-13 2021-03-19 合肥合源药业有限公司 瑞舒伐他汀钙组合物的制备方法
TWI724629B (zh) 2018-11-16 2021-04-11 日商協和化學工業股份有限公司 緩瀉用錠劑
CN111281855B (zh) * 2020-03-23 2021-09-24 乐普制药科技有限公司 一种雷贝拉唑肠溶片及其制备方法
CN115487160A (zh) * 2022-09-27 2022-12-20 威海百合生物技术股份有限公司 一种氧化镁片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921707A (en) * 1986-06-24 1990-05-01 Istvan Racz Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability
JP2731854B2 (ja) * 1989-02-10 1998-03-25 協和化学工業株式会社 高耐水和性、高流動性酸化マグネシウムの製造方法
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
IT1250701B (it) * 1991-07-24 1995-04-21 Angelini Francesco Ist Ricerca Composizione farmaceutica solida per uso orale a base di dapiprazolo
JP2711614B2 (ja) * 1992-06-10 1998-02-10 新日本製鐵株式会社 皮膜特性及び磁気特性の優れた方向性電磁鋼板の製造方法
JPH0940561A (ja) * 1995-08-02 1997-02-10 Fujitsukusu Kk 瀉下剤
JPH10120416A (ja) * 1996-10-17 1998-05-12 Kyowa Chem Ind Co Ltd 水懸濁用水酸化マグネシウム粉末
JP2000001428A (ja) * 1998-04-16 2000-01-07 Nippon Shinyaku Co Ltd 錠剤及び製造法
JP2001048792A (ja) * 1998-11-26 2001-02-20 Fujix Kk 瀉下剤

Also Published As

Publication number Publication date
KR20090065552A (ko) 2009-06-22
HK1061641A1 (en) 2004-09-30
CN1473049A (zh) 2004-02-04
RU2284189C2 (ru) 2006-09-27
NO333440B1 (no) 2013-06-03
DE60224056D1 (de) 2008-01-24
EP1421944B1 (de) 2007-12-12
PT1421944E (pt) 2008-01-03
US7147868B2 (en) 2006-12-12
EP1421944A1 (de) 2004-05-26
DK1421944T3 (da) 2008-03-31
CN1262278C (zh) 2006-07-05
CA2424554A1 (en) 2003-03-06
AU2002318630B2 (en) 2007-05-17
TWI331044B (en) 2010-10-01
ES2296960T3 (es) 2008-05-01
EP1421944A4 (de) 2005-08-31
NO20031873L (no) 2003-04-25
KR100972773B1 (ko) 2010-07-30
NO20031873D0 (no) 2003-04-25
MY134676A (en) 2007-12-31
KR20080099353A (ko) 2008-11-12
US20040022872A1 (en) 2004-02-05
DE60224056T2 (de) 2008-12-04
WO2003018034A1 (fr) 2003-03-06
MXPA03003292A (es) 2004-12-13
KR20040044385A (ko) 2004-05-28
CA2424554C (en) 2009-08-18

Similar Documents

Publication Publication Date Title
ATE380546T1 (de) Antazide und laxative magnesiumoxid-tablette
HUP0003897A2 (hu) Pezsgő sav-bázis párt tartalmazó gyógyászati kompozíciók
NZ548351A (en) Direct compression formulation and process
RU2004118709A (ru) Составы, содержащие азитромицин, поддающиеся прямому прессованию
DE69934135D1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
ES2190241T3 (es) Compuestos farmaceuticos de liberacion rapida de substancias medicamentosas.
EA200400045A1 (ru) Система для ингаляции сухим порошком для транспульмонарного применения
WO2003028703A3 (en) Immediate release tablet
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
ID29837A (id) Formulasi dosis oral yang mencair seketika
HUP9801615A2 (hu) Szimetikon/vízmentes kalcium-foszfát-kompozíciók
BR0116556A (pt) Composição farmacêutica e seu uso, processo para tratamento ou prevenção de angina ou hipertensão ou falha cardìaca, processo para fazer a composição, processo e comprimido
RU2003112224A (ru) Антацидная и слабительная таблетка
MY127350A (en) Flash-melt oral dose formulations
HU9603463D0 (en) Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl) propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
EA200701107A1 (ru) Твердая фармацевтическая композиция, содержащая валсартан
ATE329582T1 (de) Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit
RU2006104009A (ru) Фармацевтическая препаративная форма
WO2003028624A3 (en) Levothyroxine compositions and methods
TW200420230A (en) Packaged tea drink
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
RU2009118826A (ru) Эсциталопрам и твердая фармацевтическая композиция, его содержащая
CA2450233A1 (en) Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
WO2004000223A3 (en) Rapidly disintegrating formulations for treating or preventing mucositis
WO2003013441A3 (en) Levothyroxine compositions and methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1421944

Country of ref document: EP